Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josh Levitsky

Showing results (171-180 of 199) with videos related to

Pageof 20
Sort By:
Hepatology (Baltimore, Md.)|January 12, 2012
Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipientsJosh Levitsky, James M Mathew, Michael Abecassis, et al.
Transplantation|September 29, 2022
Personality Traits in Patients With Cirrhosis Are Different From Those of the General Population and Impact Likelihood of Liver TransplantationAvesh J Thuluvath, Osama Siddiqui, Jennifer C Lai, et al.
Cardiovascular and Interventional Radiology|June 10, 2024
Percutaneous Biliary Interventions via the Modified Hutson Loop in Patients with Biliary-Enteric Anastomoses: A Retrospective StudyAli Husnain, Asad Malik, Juan Caicedo, et al.
Gastroenterology|January 31, 2012
Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferonJosh Levitsky, Maria Isabel Fiel, John P Norvell, et al.
Academic Radiology|August 11, 2012
MRI-guided biopsy to correlate tissue specimens with MR elastography stiffness readings in liver transplantsRyan B Perumpail, Josh Levitsky, Yi Wang, et al.
Transplantation|July 27, 2023
Brief PROMIS Assessment Screens for Frailty and Predicts Hospitalizations in Liver Transplant CandidatesAvesh J Thuluvath, Andres Duarte-Rojo, Jennifer C Lai, et al.
Analytical Chemistry|February 14, 2024
Targeted Quantification of Proteoforms in Complex Samples by Proteoform Reaction MonitoringChe-Fan Huang, Jake T Kline, Fernanda Negrão, et al.
Clinical Transplantation|February 8, 2023
Early initiation of glecaprevir/pibrentasvir after transplantation of HCV-viremic kidneys into HCV-negative recipients is associated with normalization in the altered inflammatory milieuMyung-Ho Kim, Meghan E Sise, Min Xu, et al.
Hepatology Communications|October 9, 2019
Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV-TARGET AnalysisKavita Radhakrishnan, Adrian M Di Bisceglie, K Rajender Reddy, et al.
The New England Journal of Medicine|November 12, 2014
An interferon-free antiviral regimen for HCV after liver transplantationPaul Y Kwo, Parvez S Mantry, Eoin Coakley, et al.
Pageof 20

Showing results (171-180 of 199) with videos related to

Sort By:
Pageof 20
Hepatology (Baltimore, Md.)|January 12, 2012
Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipientsJosh Levitsky, James M Mathew, Michael Abecassis, et al.
Transplantation|September 29, 2022
Personality Traits in Patients With Cirrhosis Are Different From Those of the General Population and Impact Likelihood of Liver TransplantationAvesh J Thuluvath, Osama Siddiqui, Jennifer C Lai, et al.
Cardiovascular and Interventional Radiology|June 10, 2024
Percutaneous Biliary Interventions via the Modified Hutson Loop in Patients with Biliary-Enteric Anastomoses: A Retrospective StudyAli Husnain, Asad Malik, Juan Caicedo, et al.
Gastroenterology|January 31, 2012
Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferonJosh Levitsky, Maria Isabel Fiel, John P Norvell, et al.
Academic Radiology|August 11, 2012
MRI-guided biopsy to correlate tissue specimens with MR elastography stiffness readings in liver transplantsRyan B Perumpail, Josh Levitsky, Yi Wang, et al.
Transplantation|July 27, 2023
Brief PROMIS Assessment Screens for Frailty and Predicts Hospitalizations in Liver Transplant CandidatesAvesh J Thuluvath, Andres Duarte-Rojo, Jennifer C Lai, et al.
Analytical Chemistry|February 14, 2024
Targeted Quantification of Proteoforms in Complex Samples by Proteoform Reaction MonitoringChe-Fan Huang, Jake T Kline, Fernanda Negrão, et al.
Clinical Transplantation|February 8, 2023
Early initiation of glecaprevir/pibrentasvir after transplantation of HCV-viremic kidneys into HCV-negative recipients is associated with normalization in the altered inflammatory milieuMyung-Ho Kim, Meghan E Sise, Min Xu, et al.
Hepatology Communications|October 9, 2019
Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV-TARGET AnalysisKavita Radhakrishnan, Adrian M Di Bisceglie, K Rajender Reddy, et al.
The New England Journal of Medicine|November 12, 2014
An interferon-free antiviral regimen for HCV after liver transplantationPaul Y Kwo, Parvez S Mantry, Eoin Coakley, et al.
Pageof 20